AUPH AURINIA PHARMACEUTICALS INC Disposals and divestitures 8-K Filing 2024 - Financial Results, Program Discontinuation, Share Repurchase Program Aurinia Pharmaceuticals Inc. announced its financial results for the quarter and year ended December 31, 2023, discontinuation of certain research and development programs, and authorization of a share repurchase program.Get access to all SEC 8-K filings of the AURINIA PHARMACEUTICALS INC